Hologic to Release Fourth Quarter Fiscal 2012 Operating Results on Monday, November 12, 2012
BEDFORD, Mass., Oct. 3, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to release its fourth quarter fiscal 2012 operating results on Monday, November 12, 2012 after market close. In conjunction with the release, management will host a conference call on Monday, November 12, 2012, at 5:00 p.m. (Eastern).
Interested participants may listen to the call by dialing 877-856-1958 or 719-325-4810 for international callers and referencing code 9845290 approximately 15 minutes prior to the call on November 12th. For those unable to participate in the live broadcast, a replay will be available one hour after the call ends through Friday, November 30, 2012, at 888-203-1112 or 719-457-0820 for international callers, access code 9845290.
The Company will also provide a live webcast of the call. Interested participants may access the webcast on the Company's website at www.hologic.com/investors-overview. A replay of the call will be archived on the Company's website and a PowerPoint presentation related to the conference call will be posted to the site after market close on Monday, November 12, 2012.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.
|
Contacts: |
|
|
Deborah R. Gordon |
Al Kildani |
|
Vice President, Investor Relations |
Senior Director, Investor Relations |
|
(781) 999-7716 |
(858) 410-8653 |
SOURCE Hologic, Inc.
RELATED LINKS
http://www.hologic.com
More by this Source
Hologic riceve l'approvazione FDA per una nuova soluzione di mammografia 3D (tomosintesi al seno) a bassa dose per lo screening del tumore al seno
Jun 06, 2013, 03:00 ET
Hologic erhält FDA-Zulassung für eine neue niedrigdosierte 3D-Mammographie-Lösung (Brust-Tomosynthese) für Brustkrebs-Screening
Jun 03, 2013, 03:00 ET
Hologic reçoit l'homologation de la FDA pour sa nouvelle solution de mammographie en 3D (tomosynthèse mammaire) à faible dose utilisée dans le dépistage du cancer du sein
Jun 03, 2013, 03:00 ET
Featured Video
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
- Site Preview
-
Close Site Preview
-
View FullScreen





